Influence of novel and conventional antipsychotic medication on subjective quality of life.

R Tempier, Nicole Pawliuk

PubMed · 2001 · 23 citations · 16 references

Concepts

Abstract

OBJECTIVE: To assess the impact of novel antipsychotic medication on the subjective quality of life of patients with schizophrenia and schizoaffective disorders. DESIGN: Retrospective, cross-sectional analysis of data from 2 studies conducted in 1997 and 1998. PATIENTS: 91 outpatients (50 men and 41 women, mean age 43.3 years) diagnosed with schizophrenia (n = 70) and schizoaffective disorder (n = 21); the mean Global Assessment of Functioning score for these patients was 48.0 (standard deviation 12.5). OUTCOME MEASURE: Patients were categorized into 1 of 3 groups: those taking conventional (n = 41), novel (n = 26) or mixed (both conventional and novel) (n = 24) antipsychotics. Responses on the Satisfaction with Life Domains Scale were used to assess subjective quality of life. RESULTS: The type of antipsychotic medication taken did not influence satisfaction with life scores; in fact, 2 items dealing with social relationships were scored lower by those taking novel antipsychotics. CONCLUSIONS: Patients taking novel antipsychotics may expect more from life, and this might explain their lower quality-of-life scores.

References

16